Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

This publication has 33 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Triglycerides and atherogenic lipoproteins: rationale for lipid management
  The American Journal of Medicine, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
  Circulation, 1998
• Cholesterol Reduction Yields Clinical Benefit
  Circulation, 1998
• What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?
  Atherosclerosis, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
  Circulation, 1989
• PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
  The Lancet, 1975